Association of race/ethnicity and socioeconomic status with COVID-19 30-day mortality at a Philadelphia medical center using a retrospective cohort study
© 2021 Wiley Periodicals LLC..
COVID-19 has disproportionately affected low-income communities and people of color. Previous studies demonstrated that race/ethnicity and socioeconomic status (SES) are not independently correlated with COVID-19 mortality. The purpose of our study is to determine the effect of race/ethnicity and SES on COVID-19 30-day mortality in a diverse, Philadelphian population. This is a retrospective cohort study in a single-center tertiary care hospital in Philadelphia, PA. The study includes adult patients hospitalized with polymerase-chain-reaction-confirmed COVID-19 between March 1, 2020 and June 6, 2020. The primary outcome was a composite of COVID-19 death or hospice discharge within 30 days of discharge. The secondary outcome was intensive care unit (ICU) admission. The study included 426 patients: 16.7% died, 3.3% were discharged to hospice, and 20.0% were admitted to the ICU. Using multivariable analysis, race/ethnicity was not associated with the primary nor secondary outcome. In Model 4, age greater than 75 (odds ratio [OR]: 11.01; 95% confidence interval [CI]: 1.96-61.97) and renal disease (OR: 2.78; 95% CI: 1.31-5.90) were associated with higher odds of the composite primary outcome. Living in a "very-low-income area" (OR: 0.29; 95% CI: 0.12-0.71) and body mass index (BMI) 30-35 (OR: 0.24; 95% CI: 0.08-0.69) were associated with lower odds of the primary outcome. When controlling for demographics, SES, and comorbidities, race/ethnicity was not independently associated with the composite primary outcome. Very-low SES, as extrapolated from census-tract-level income data, was associated with lower odds of the composite primary outcome.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:94 |
|---|---|
| Enthalten in: |
Journal of medical virology - 94(2022), 3 vom: 05. März, Seite 906-917 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Cheney-Peters, Dianna R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biostatistics & bioinformatics |
|---|
| Anmerkungen: |
Date Completed 03.06.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/jmv.27365 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331273055 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331273055 | ||
| 003 | DE-627 | ||
| 005 | 20231225213111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jmv.27365 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM331273055 | ||
| 035 | |a (NLM)34585772 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cheney-Peters, Dianna R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association of race/ethnicity and socioeconomic status with COVID-19 30-day mortality at a Philadelphia medical center using a retrospective cohort study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.06.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021 Wiley Periodicals LLC. | ||
| 520 | |a COVID-19 has disproportionately affected low-income communities and people of color. Previous studies demonstrated that race/ethnicity and socioeconomic status (SES) are not independently correlated with COVID-19 mortality. The purpose of our study is to determine the effect of race/ethnicity and SES on COVID-19 30-day mortality in a diverse, Philadelphian population. This is a retrospective cohort study in a single-center tertiary care hospital in Philadelphia, PA. The study includes adult patients hospitalized with polymerase-chain-reaction-confirmed COVID-19 between March 1, 2020 and June 6, 2020. The primary outcome was a composite of COVID-19 death or hospice discharge within 30 days of discharge. The secondary outcome was intensive care unit (ICU) admission. The study included 426 patients: 16.7% died, 3.3% were discharged to hospice, and 20.0% were admitted to the ICU. Using multivariable analysis, race/ethnicity was not associated with the primary nor secondary outcome. In Model 4, age greater than 75 (odds ratio [OR]: 11.01; 95% confidence interval [CI]: 1.96-61.97) and renal disease (OR: 2.78; 95% CI: 1.31-5.90) were associated with higher odds of the composite primary outcome. Living in a "very-low-income area" (OR: 0.29; 95% CI: 0.12-0.71) and body mass index (BMI) 30-35 (OR: 0.24; 95% CI: 0.08-0.69) were associated with lower odds of the primary outcome. When controlling for demographics, SES, and comorbidities, race/ethnicity was not independently associated with the composite primary outcome. Very-low SES, as extrapolated from census-tract-level income data, was associated with lower odds of the composite primary outcome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a SARS coronavirus | |
| 650 | 4 | |a biostatistics & bioinformatics | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a infection | |
| 650 | 4 | |a pandemics | |
| 650 | 4 | |a public policy | |
| 650 | 4 | |a social science | |
| 650 | 4 | |a virus classification | |
| 700 | 1 | |a Lee, Crystal Y |e verfasserin |4 aut | |
| 700 | 1 | |a Mitsuhashi, Shuji |e verfasserin |4 aut | |
| 700 | 1 | |a Zaret, Dina S |e verfasserin |4 aut | |
| 700 | 1 | |a Riley, Joshua M |e verfasserin |4 aut | |
| 700 | 1 | |a Venkataraman, Chantel M |e verfasserin |4 aut | |
| 700 | 1 | |a Schaefer, Joseph W |e verfasserin |4 aut | |
| 700 | 1 | |a George, Brandon J |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Chris J |e verfasserin |4 aut | |
| 700 | 1 | |a Smaltz, Christa M |e verfasserin |4 aut | |
| 700 | 1 | |a Bradley, Conor G |e verfasserin |4 aut | |
| 700 | 1 | |a Fitzpatrick, Danielle M |e verfasserin |4 aut | |
| 700 | 1 | |a Ney, David B |e verfasserin |4 aut | |
| 700 | 1 | |a Chalikonda, Divya M |e verfasserin |4 aut | |
| 700 | 1 | |a Mairose, Joshua D |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Kashyap |e verfasserin |4 aut | |
| 700 | 1 | |a Szot, Margaret V |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Robert B |e verfasserin |4 aut | |
| 700 | 1 | |a Bashir-Hamidu, Rukaiya |e verfasserin |4 aut | |
| 700 | 1 | |a Kubey, Alan A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medical virology |d 1990 |g 94(2022), 3 vom: 05. März, Seite 906-917 |w (DE-627)NLM000285676 |x 1096-9071 |7 nnns |
| 773 | 1 | 8 | |g volume:94 |g year:2022 |g number:3 |g day:05 |g month:03 |g pages:906-917 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jmv.27365 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 94 |j 2022 |e 3 |b 05 |c 03 |h 906-917 | ||